Dicerna Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 238,000 shares of common stock to be distributed among six new employees, with a grant date of March 1, 2019.
March 1, 2019
· 3 min read